Greg has 30 years of experience in analytical development, specializing in the mass spectrometric characterization of protein based biopharmaceuticals. He received his doctorate from the University of Adelaide followed by postdoctoral research at the University of California, San Francisco. Greg has spent the majority of his career at FUJIFILM Diosynth Biotechnologies (FDB) in analytical development supporting the characterization and method development of biotherapeutic proteins in clinical development and commercial production. In his current role he is responsible for strategic projects related to FDB’s analytical service offerings, innovation and evaluation of new analytical technologies and industry collaborations.